Evaluation of Performance, Safety and Benefit of the Wishbone HA as Bone Graft Substitute, a Pre-market Clinical Investigation

Recruiting N/A Interventional Study
Bone Regeneration Safety Issues
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
96 (estimated)
Sponsor
Wishbone SA · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This investigation is a pre-market, prospective, multi-center, randomized, single blinded, parallel controlled clinical investigation performed in at least 5 clinical centers for confirmatory purposes of the use of WHA as intended in the filling of extraction sockets to enhance preservation of the alveolar socket.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * The subject signed the informed consent form; * The subject is ≥ 18 and ≤ 80 years old at surgery; * The subject is in need of a tooth extraction prior to implant placement; * All four bony walls are preserved after extraction; * Minimum 8mm height of bone; * Minimum 7mm thick…
Contacts

Emilie Dory, CEO

+32484706172

emilie.dory@wishbone-biotech.com

CONTACT

Justine Pirson, R&D Manager

+3249487202

justine.pirson@wishbone-biotech.com

CONTACT